Print Digg

Article

Mitochondrial clean-up to prevent and treat Age Related Macular Degeneration. Acetyl-L-Cartinine, CoQ10, Vitamin E

Friday, August 29, 2003


A histopathologic study recently published in the September 2003 peer-reviewed issue of Ophthalmologica shows that nutrient compounds, which improve mitochondrial functions, show beneficial effects in preventing and treating Age Related Macular Degeneration (AMD).

Fourteen patients affected by early AMD were treated with a multiple nutrient formulation containing acety -L-carnitine, coenzyme Q10 and vitamin E and EFAs, while a matched group affected by early AMD were treated with vitamin E only. In the multiple nutrient treatment group, all the visual functions showed improvement, which was evident after three months of treatment and remained nearly stationary by the end of 24 months. The same tests in the control group showed slow progressive worsening. The findings suggest that the blend of these specific nutrients can improve retinal functions in early AMD.
 
Ellen Troyer, MT MA - Biosyntrx Chief Research Officer
Spencer Thornton, MD - Biosyntrx President

PEARL

Based on an extensive body of peer-reviewed mitochondria research literature, Biosyntrx included these (albeit expensive) specific nutrients in our full body Macula Complete formulation. To our knowledge, no other AMD formulation available in today's market place appropriately addresses the pathophysiology of cellular mitochondria and the relationship to eye disease.

References

Mitotropic compounds for the treatment of age-related macular degeneration. The metabolic approach and a pilot study. Feher J, Papale A, et al. Ophthalmologica, 2003 Sept-Oct;217(5):351-7